Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


28.11.2022

1 Acta Derm Venereol
4 Allergy
1 Contact Dermatitis
3 Eur Respir J
4 J Allergy Clin Immunol
20 J Asthma
1 J Dermatol
1 J Immunol
1 Pediatr Dermatol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Derm Venereol

  1. BOESJES CM, Kamphuis E, Zuithoff NPA, Bakker DS, et al
    Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
    Acta Derm Venereol. 2022;102:adv00820.
    PubMed         Abstract available


    Allergy

  2. POLAK D, Vollmann U, Grilo J, Bogdanov IV, et al
    Bet v 1-independent sensitization to major allergens in Fagales pollen: evidence at the T cell level.
    Allergy. 2022 Nov 24. doi: 10.1111/all.15594.
    PubMed         Abstract available

  3. MUSIOL S, Harris CP, Karlina R, Gostner JM, et al
    Dietary digestible carbohydrates are associated with higher prevalence of asthma in humans and with aggravated lung allergic inflammation in mice.
    Allergy. 2022 Nov 24. doi: 10.1111/all.15589.
    PubMed         Abstract available

  4. SPEKHORST LS, van de Rijst LP, de Graaf M, van Megen M, et al
    Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients.
    Allergy. 2022 Nov 24. doi: 10.1111/all.15591.
    PubMed        

  5. LIN TM, Hsu HC, Shen YC, Chang YS, et al
    GALTectomy increases the risk of allergic rhinitis: A nationwide population-based cohort study.
    Allergy. 2022 Nov 22. doi: 10.1111/all.15588.
    PubMed        


    Contact Dermatitis

  6. LLAMAS-MOLINA JM, Prados-Carmona A, Velasco-Amador P, Ruiz-Villaverde R, et al
    Allergic contact dermatitis caused by herbicide containing glyphosate-isopropylamine salt.
    Contact Dermatitis. 2022 Nov 23. doi: 10.1111/cod.14252.
    PubMed        


    Eur Respir J

  7. PETSKY H
    Randomised controlled trials utilising F ENO to manage asthma: is it time to acknowledge that "one size does not fit all"?
    Eur Respir J. 2022;60.
    PubMed        

  8. PERSSON C
    Creola bodies and pathogenesis of childhood asthma.
    Eur Respir J. 2022 Sep 30. pii: 13993003.01204-2022.
    PubMed        

  9. MURPHY VE, Jensen ME, Holliday EG, Giles WB, et al
    Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00298-2022.
    PubMed         Abstract available


    J Allergy Clin Immunol

  10. HUFFAKER MF, Kanchan K, Bahnson HT, Ruczinski I, et al
    Epidermal Differentiation Complex Genetic Variation in Atopic Dermatitis and Peanut Allergy.
    J Allergy Clin Immunol. 2022 Nov 17:S0091-6749(22)01566.
    PubMed         Abstract available

  11. HASHIMOTO T, Yokozeki H, Karasuyama H, Satoh T, et al
    IL-31-generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin.
    J Allergy Clin Immunol. 2022 Nov 18:S0091-6749(22)01567.
    PubMed         Abstract available

  12. LEWIS SA, Peters B
    T-cell epitope discovery and single-cell technologies to advance food allergy research.
    J Allergy Clin Immunol. 2022 Nov 18:S0091-6749(22)01483.
    PubMed         Abstract available

  13. SCHULER CF 4TH, Billi AC, Maverakis E, Tsoi LC, et al
    Novel insights into atopic dermatitis.
    J Allergy Clin Immunol. 2022 Nov 22:S0091-6749(22)01480.
    PubMed         Abstract available


    J Asthma

  14. LAM RW, Inselman JW, Jeffery MM, Maddux JT, et al
    Asthma biologic trial eligibility and real-world outcomes in the United States.
    J Asthma. 2021 Nov 24:1-12. doi: 10.1080/02770903.2021.2010749.
    PubMed         Abstract available

  15. ROGERSON CM, He T, Rowan C, Tu W, et al
    Ten Year Trends in Hospital Encounters for Pediatric Asthma: An Indiana Experience.
    J Asthma. 2021 Nov 24:1-11. doi: 10.1080/02770903.2021.2010750.
    PubMed         Abstract available

  16. KAUR S, Rosenstreich D, Cleven KL, Spivack S, et al
    Severe Asthma in Adult, Inner-city predominantly African-American and Latinx Population: Demographic, Clinical and Phenotypic Characteristics.
    J Asthma. 2021 Nov 25:1-15. doi: 10.1080/02770903.2021.2010748.
    PubMed         Abstract available

  17. ASAMOAH-BOAHENG M, Farrell J, Osei Bonsu K, Midodzi WK, et al
    Determining the optimal threshold for medication adherence in adult asthma patients: An analysis of British Columbia administrative health database in Canada.
    J Asthma. 2021 Dec 6:1-15. doi: 10.1080/02770903.2021.2014862.
    PubMed         Abstract available

  18. CORNWELL CR, Hsu J, Tompkins LK, Pennington AF, et al
    Clinical outcomes among hospitalized US adults with asthma or chronic obstructive pulmonary disease, with or without COVID-19.
    J Asthma. 2021 Dec 13:1-16. doi: 10.1080/02770903.2021.2018703.
    PubMed         Abstract available

  19. AL WADHAHI A, Garvey L, Edward KL, Beasley C, et al
    The Lived Experience of Adherence to Asthma Medication in Young Adults (18-34 years).
    J Asthma. 2021 Dec 13:1-23. doi: 10.1080/02770903.2021.2018706.
    PubMed         Abstract available

  20. SHAHUNJA KM, Sly PD, Begum T, Biswas T, et al
    Family, neighborhood and psychosocial environmental factors and their associations with asthma in Australia: a systematic review and Meta-analysis.
    J Asthma. 2021 Dec 24:1-14. doi: 10.1080/02770903.2021.2018707.
    PubMed         Abstract available

  21. HAYNES SC, Kamerman-Kretzmer R, Khan SS, Crossen S, et al
    Telemedicine Use for Pediatric Asthma Care: A Mixed Methods Study.
    J Asthma. 2021 Dec 16:1-14. doi: 10.1080/02770903.2021.2019265.
    PubMed         Abstract available

  22. ANTONIO BUENDIA J, Patino DG
    SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis.
    J Asthma. 2021 Dec 16:1-9. doi: 10.1080/02770903.2021.2019266.
    PubMed         Abstract available

  23. GAURAV R, Poole JA
    Interleukin (IL)-33 Immunobiology in Asthma and Airway Inflammatory Diseases.
    J Asthma. 2021 Dec 20:1-13. doi: 10.1080/02770903.2021.2020815.
    PubMed         Abstract available

  24. DAVIS P, Edie AH, Rushton S, Cleven K, et al
    Quality Improvement Project to Increase Screening and Referral for Biologic Therapy for Patients with Uncontrolled Asthma.
    J Asthma. 2021 Dec 20:1-10. doi: 10.1080/02770903.2021.2020814.
    PubMed         Abstract available

  25. BRAIDO F, Tiotiu A, Guidos-Fogelbach G, Baiardini I, et al
    Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document.
    J Asthma. 2021 Dec 22:1-16. doi: 10.1080/02770903.2021.2022160.
    PubMed         Abstract available

  26. OTANI T, Iwamoto H, Yoshida Y, Yamaguchi K, et al
    Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: A case report.
    J Asthma. 2021 Dec 22:1-8. doi: 10.1080/02770903.2021.2022158.
    PubMed         Abstract available

  27. O'NEILL CD, Patlan I, Jeffery M, Lewis D, et al
    Effects of high intensity interval training on cardiorespiratory fitness and salivary levels of IL-8, IL-1ra, and IP-10 in adults with asthma and non-asthma controls.
    J Asthma. 2021 Dec 28:1-10. doi: 10.1080/02770903.2021.2018702.
    PubMed         Abstract available

  28. MAMMEN JR, McGovern CM, Schoonmaker JD, Philibert A, et al
    A multilevel perspective on goals, barriers, and facilitators of school-based asthma management.
    J Asthma. 2021 Dec 28:1-14. doi: 10.1080/02770903.2021.2018704.
    PubMed         Abstract available

  29. FOX CW, Khaw CL, Gerke AK, Lund BC, et al
    Montelukast and neuropsychiatric events - a sequence symmetry analysis.
    J Asthma. 2022;59:2360-2366.
    PubMed         Abstract available

  30. LUGOGO N, Judson E, Haight E, Trudo F, et al
    Severe asthma exacerbation rates are increased among female, Black, Hispanic, and younger adult patients: results from the US CHRONICLE study.
    J Asthma. 2022 Jan 9:1-14. doi: 10.1080/02770903.2021.2018701.
    PubMed         Abstract available

  31. CLEMONS R, Kong M, Jawad K, Feygin Y, et al
    The Impact of Converting a Power Plant from Coal to Natural Gas on Pediatric Acute Asthma.
    J Asthma. 2022 Jan 17:1-12. doi: 10.1080/02770903.2021.2022159.
    PubMed         Abstract available

  32. KOISTINEN V, Kauppi P, Idanpaan-Heikkila J, Veijalainen L, et al
    Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in Finland.
    J Asthma. 2022 Jan 30:1-11. doi: 10.1080/02770903.2021.2020813.
    PubMed         Abstract available

  33. KAN A, Sen V
    The use of puzzles in inhaler technique training.
    J Asthma. 2022;59:2413-2420.
    PubMed         Abstract available


    J Dermatol

  34. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16635.
    PubMed         Abstract available


    J Immunol

  35. KASAKURA K, Kawakami Y, Jacquet A, Kawakami T, et al
    Histamine-Releasing Factor Is a Novel Alarmin Induced by House Dust Mite Allergen, Cytokines, and Cell Death.
    J Immunol. 2022;209:1851-1859.
    PubMed         Abstract available


    Pediatr Dermatol

  36. ANAND P, Schneeweiss S, Mostaghimi A, Schneeweiss MC, et al
    Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
    Pediatr Dermatol. 2022 Nov 20. doi: 10.1111/pde.15172.
    PubMed         Abstract available


    PLoS One

  37. LISBOA RO, Sekula RF, Bezamat M, Deeley K, et al
    Pain perception genes, asthma, and oral health: A reverse genetics study.
    PLoS One. 2022;17:e0277036.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: